On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Leyden Delta BV's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€143k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- CRESTARPartner
Pharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophrenia
FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗
€143ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Aarhus UniversitetDenmark · 1 shared project
- Ludwig-Maximilians-Universitaet MuenchenGermany · 1 shared project
- King'S College LondonUnited Kingdom · 1 shared project
- Cardiff UniversityUnited Kingdom · 1 shared project
- Martin-Luther-Universitat Halle-WittenbergGermany · 1 shared project
- Zentralinstitut Fuer Seelische GesundheitGermany · 1 shared project
- Islensk Erfdagreining EhfIceland · 1 shared project
- Concentris Research Management GmbHGermany · 1 shared project
- Landspitali University HospitalIceland · 1 shared project
- Eli Lilly and Company LtdUnited Kingdom · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- adverse drug reactions
- databases
- genomes
- schizophrenia
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗